HCQ and QTc in RA and SLE Patients: Dr. Kathryn Dao
Dr. Kathryn Dao reviews abstract #0431 presented at the 2020 ACR annual meeting.
Lifestyle, Clinical Risk Factors for RA-ILD: Dr. Sheila Reyes
Dr. Sheila Reyes reviews abstract #1198 presented at the 2020 ACR annual meeting.
MAGIC Syndrome in Relapsing Polychondritis: Dr. Bella Mehta
Dr. Bella Mehta reviews abstract #0425 presented at the 2020 ACR annual meeting.
iRAEs, Treatments for Checkpoint Inhibitor Inflammatory Arthritis and PMR
Dr. Alexa Meara interviews Dr. Cassie Calabrese about iRAEs as well as Checkpoint Inhibitor Inflammatory Arthritis and PMR at the 2020 ACR annual meeting.
Warfarin and End-Stage Osteoarthritis: Dr. David Liew
Dr. David Liew discusses abstract #0934 presented at the 2020 ACR annual meeting.
Impact of Exercise on Sleep in RA: Dr. Kathryn Dao
Dr. Kathryn Dao discusses abstract #0134 presented Friday at the 2020 ACR annual meeting.
XRay Bone Erosions in CCP+ Patients: Dr Eric Dein
Dr. Eric Dein discusses abstract #0760 presented at the 2020 ACR annual meeting.
Combo Therapy v Monotherapy (SEAM-RA Trial): Dr. Richard Conway
Dr. Conway discusses ACR abstract #0939 presented Saturday at the 2020 ACR annual meeting.
Treatment of Dermatomyositis Studies: Dr Robert Chao
Dr. Robert Chao reviews two important abstracts - #0955 (IVIg) and #0958 (tocilizumab) - on the treatment of dermatomyositis as presented at the 2020 ACR annual meeting.
What is the SEAMless transition from combination Etanercept to Methotrexate? Dr. Jonathan Kay
Dr. Jonathan Kay takes a deep dive into plenary abstract #0939 presented at the ACR 2020 annual meeting, reviewing two previous clinical trials that also looked at this question and offering his perspective.
Staying on Therapy in RA: Dr. Janet Pope
Dr. Janet Pope reviews abstract #0804 - Factors That Influence Biological Survival in Rheumatoid Arthritis: Results of a Real-world Cohort from the Netherlands- presented at the ACR 2020 annual meeting.
Treat to Target in Spondyloarthritis: Dr. Rachel Tate
Dr. Tate discusses abstracts #0879, #0893 and #1892 presented at the ACR20 annual meeting.
Representation of Women Authors in Rheumatology: Dr Bella Mehta
Dr. Bella Mehta reviews abstract #0440 presented at the 2020 ACR annual meeting.
Improving Drug Adherence in RA: Dr. Janet Pope
Dr. Janet Pope reviews abstract #0799 presented Saturday at the ACR 2020 annual meeting.
SEAM-RA Trial: Dr. Jeff Curtis
Dr. Jeff Curtis discusses abstract #0939, which looked at whether RA patients at or close to remission should continue taking their combination therapy, as presented at ACR 2020.
Poster Hall